DRUG COMBINATION FOR THE TREATMENT OF DEPRESSION AND RELATED DISORDERS COMPRISING A SELECTIVE SEROTONIN REUPTAKE INHIBITOR

摘要

The invention provides for a combination comprising an amount of an SSRI, or a pharmaceutically acceptable salt or solvate thereof, and an amount of a GR antagonist, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers for use as therapy for depression and related disorders.